Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Bone Biologics Corp. (BBLG) had Stock-Based Compensation of $0.21M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.67M |
|
-- |
|
-- |
|
$0.72M |
|
$-0.72M |
|
$0.05M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.72M |
|
$-0.72M |
|
1.80M |
|
1.80M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$6.35M |
|
-- |
|
-- |
|
$6.35M |
|
$0.33M |
|
-- |
|
-- |
|
$0.33M |
|
$6.02M |
|
$6.02M |
|
$6.02M |
|
1.79M |
|
| Cash Flow Statement Financials | |
$-1.98M |
|
-- |
|
$4.70M |
|
$3.33M |
|
$6.05M |
|
$2.72M |
|
|
Stock-Based Compensation |
$0.21M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.08% |
|
-11.08% |
|
-10.50% |
|
-11.08% |
|
$3.35 |
|
$-1.10 |
|
$-1.10 |
|